190 related articles for article (PubMed ID: 24096023)
1. Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.
Wang D; Krilich J; Pellett S; Baudys J; Tepp WH; Barr JR; Johnson EA; Kalb SR
Biochim Biophys Acta; 2013 Dec; 1834(12):2722-8. PubMed ID: 24096023
[TBL] [Abstract][Full Text] [Related]
2. Catalytic properties of botulinum neurotoxin subtypes A3 and A4.
Henkel JS; Jacobson M; Tepp W; Pier C; Johnson EA; Barbieri JT
Biochemistry; 2009 Mar; 48(11):2522-8. PubMed ID: 19256469
[TBL] [Abstract][Full Text] [Related]
3. Purification, modeling, and analysis of botulinum neurotoxin subtype A5 (BoNT/A5) from Clostridium botulinum strain A661222.
Jacobson MJ; Lin G; Tepp W; Dupuy J; Stenmark P; Stevens RC; Johnson EA
Appl Environ Microbiol; 2011 Jun; 77(12):4217-22. PubMed ID: 21515732
[TBL] [Abstract][Full Text] [Related]
4. Association of botulinum neurotoxin serotype A light chain with plasma membrane-bound SNAP-25.
Chen S; Barbieri JT
J Biol Chem; 2011 Apr; 286(17):15067-72. PubMed ID: 21378164
[TBL] [Abstract][Full Text] [Related]
5. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
Jin R; Sikorra S; Stegmann CM; Pich A; Binz T; Brunger AT
Biochemistry; 2007 Sep; 46(37):10685-93. PubMed ID: 17718519
[TBL] [Abstract][Full Text] [Related]
6. Light chain separated from the rest of the type a botulinum neurotoxin molecule is the most catalytically active form.
Gul N; Smith LA; Ahmed SA
PLoS One; 2010 Sep; 5(9):e12872. PubMed ID: 20877571
[TBL] [Abstract][Full Text] [Related]
7. Unique substrate recognition by botulinum neurotoxins serotypes A and E.
Chen S; Barbieri JT
J Biol Chem; 2006 Apr; 281(16):10906-11. PubMed ID: 16478727
[TBL] [Abstract][Full Text] [Related]
8. A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4.
Arndt JW; Jacobson MJ; Abola EE; Forsyth CM; Tepp WH; Marks JD; Johnson EA; Stevens RC
J Mol Biol; 2006 Sep; 362(4):733-42. PubMed ID: 16938310
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
10. Glycine insertion at protease cleavage site of SNAP25 resists cleavage but enhances affinity for botulinum neurotoxin serotype A.
Ho M; Goh CH; Brothers MC; Wang S; Young RL; Ou Y; Lui JN; Kalafatis M; Lan X; Wolf AE; Rienstra CM; Wilson BA
Protein Sci; 2012 Mar; 21(3):318-26. PubMed ID: 22170566
[TBL] [Abstract][Full Text] [Related]
11. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
12. Identification of residues surrounding the active site of type A botulinum neurotoxin important for substrate recognition and catalytic activity.
Ahmed SA; Olson MA; Ludivico ML; Gilsdorf J; Smith LA
Protein J; 2008 Apr; 27(3):151-62. PubMed ID: 18213512
[TBL] [Abstract][Full Text] [Related]
13. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.
Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O
Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358
[TBL] [Abstract][Full Text] [Related]
14. Development of a fluorescence internal quenching correction factor to correct botulinum neurotoxin type A endopeptidase kinetics using SNAPtide.
Feltrup TM; Singh BR
Anal Chem; 2012 Dec; 84(24):10549-53. PubMed ID: 23181535
[TBL] [Abstract][Full Text] [Related]
15. High level expression of the light chain of botulinum neurotoxin serotype C1 and an efficient HPLC assay to monitor its proteolytic activity.
Rawat R; Ashraf Ahmed S; Swaminathan S
Protein Expr Purif; 2008 Aug; 60(2):165-9. PubMed ID: 18482846
[TBL] [Abstract][Full Text] [Related]
16. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
17. SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E.
Agarwal R; Swaminathan S
J Biol Chem; 2008 Sep; 283(38):25944-51. PubMed ID: 18658150
[TBL] [Abstract][Full Text] [Related]
18. Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro.
Ekong TAN; Feavers IM; Sesardic D
Microbiology (Reading); 1997 Oct; 143 ( Pt 10)():3337-3347. PubMed ID: 9353935
[TBL] [Abstract][Full Text] [Related]
19. Development of a fusion protein SNVP as substrate for assaying multi-serotype botulinum neurotoxins.
Luo S; Li T; Wang Q; Tian R; Liu H; Fang H; Chen F; Wang H
Anal Biochem; 2014 Oct; 463():75-81. PubMed ID: 23851341
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.
Arndt JW; Yu W; Bi F; Stevens RC
Biochemistry; 2005 Jul; 44(28):9574-80. PubMed ID: 16008342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
